ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY Trademark

Trademark Overview

On Thursday, January 18, 2007, a trademark application was filed for ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY with the United States Patent and Trademark Office. The USPTO has given the ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY trademark a serial number of 77085410. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2011. This trademark is owned by Bristol-Myers Squibb Company. The ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations and/or diagnostic imaging agents for human use
ability apixaban investigation to lower the incidence of thromboembolic events in cancer therapy

General Information

Serial Number77085410
Word MarkABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY
Filing DateThursday, January 18, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 22, 2008

Trademark Statements

Disclaimer with Predetermined Text"APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations and/or diagnostic imaging agents for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, May 16, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 16, 2011ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 2, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, October 1, 2010EXTENSION 5 GRANTED
Tuesday, September 21, 2010EXTENSION 5 FILED
Tuesday, September 21, 2010TEAS EXTENSION RECEIVED
Thursday, March 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, March 24, 2010EXTENSION 4 GRANTED
Friday, March 19, 2010EXTENSION 4 FILED
Friday, March 19, 2010TEAS EXTENSION RECEIVED
Thursday, December 17, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 21, 2009EXTENSION 3 GRANTED
Thursday, September 17, 2009EXTENSION 3 FILED
Thursday, September 17, 2009TEAS EXTENSION RECEIVED
Friday, May 29, 2009ASSIGNED TO EXAMINER
Thursday, April 2, 2009EXTENSION 2 GRANTED
Monday, March 16, 2009EXTENSION 2 FILED
Thursday, April 2, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 16, 2009TEAS EXTENSION RECEIVED
Monday, September 29, 2008EXTENSION 1 GRANTED
Monday, September 29, 2008EXTENSION 1 FILED
Monday, September 29, 2008TEAS EXTENSION RECEIVED
Tuesday, April 15, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 22, 2008PUBLISHED FOR OPPOSITION
Wednesday, January 2, 2008NOTICE OF PUBLICATION
Thursday, December 20, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 20, 2007ASSIGNED TO LIE
Tuesday, November 13, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 2, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 2, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 2, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 18, 2007NON-FINAL ACTION MAILED
Thursday, May 17, 2007NON-FINAL ACTION WRITTEN
Monday, May 7, 2007ASSIGNED TO EXAMINER
Tuesday, January 23, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

events cancer therapy thromboembolic incidence apixaban investigation lower ability preparations pharmaceutical diagnostic imaging human agents relating trials research scientific